<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
p.m921630566209779715msolistparagraph, li.m921630566209779715msolistparagraph, div.m921630566209779715msolistparagraph
{mso-style-name:m_921630566209779715msolistparagraph;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.gmaildefault
{mso-style-name:gmail_default;}
span.EmailStyle22
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:110438530;
mso-list-template-ids:1651653566;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:877469972;
mso-list-template-ids:1737672550;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal">Dear all,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">During the consolidation subgroup meeting last week, I raised a point regarding amicus participation in IRPs, which some of us agreed would greatly benefit from discussion with the larger group. Accordingly, I have outlined my points below
for discussion:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">In the minds of most, including international arbitrators and at least US based lawyers, “amicus” suggests a limited role that may be inconsistent with what is fair in a particular dispute, or may be inconsistent with due process. Indeed,
the term “amicus” has specific meaning in the law; traditionally, amici are given very limited participation, whether in court or arbitration. While I am unclear regarding the limitations of the ICANN process associated with changing the term “amicus” itself,
assume for purposes of illustration that we call “amicus” instead “Interested Entity.” Interested Entity should be allowed a level of participation appropriate to how its interests may be affected by the outcome -- without the built in bias standard plainly
suggested by the term amicus. Indeed, a set of rules that allows a serious impact on legal rights based on little participation may, as a system, be a violation of due process and subject to being stricken down. <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Rule 7 of the Interim Procedures define amicus as below:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">“Any person, group, or entity that has a material interest relevant to the DISPUTE but does not satisfy the standing requirements for a CLAIMANT set forth in the Bylaws may participate as an amicus curiae before an IRP PANEL, subject to
the limitations set forth below. Without limitation to the persons, groups, or entities that may have such a material interest, the following persons, groups, or entities shall be deemed to have a material interest relevant to the DISPUTE and, upon request
of person, group, or entity seeking to so participate, shall be permitted to participate as an amicus before the IRP PANEL…”
<a href="https://www.icann.org/en/system/files/files/irp-interim-supplementary-procedures-25oct18-en.pdf">
https://www.icann.org/en/system/files/files/irp-interim-supplementary-procedures-25oct18-en.pdf</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">The drafting history of Rule 7 (and others who participated in that process can speak to it with far more authority than I may be able to) indicates it is designed to accommodate broader third party involvement than the expression “amicus
curiae” is traditionally understood to include. The Panel’s decision in Phase I of Afilias matter concluded “nature and breadth of the amicus participation that should be afforded to the Applicant Amici in this<o:p></o:p></p>
<p class="MsoNormal">case – whether it be under the provisions of Rule 7, properly interpreted, as an exercise of the Panel’s discretion under Section 4.3(o)(v) of the Bylaws, or under relevant principles of international law” should be “broadly accorded.”
<a href="https://www.icann.org/en/system/files/files/irp-afilias-panel-decision-phase-1-redacted-12feb20-en.pdf">
https://www.icann.org/en/system/files/files/irp-afilias-panel-decision-phase-1-redacted-12feb20-en.pdf</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">While my argument is not that claims of amici should routinely equal those of full intervenors, I may start the conversation by suggesting that we devise a truly flexible standard for participation by the Interested Entity. Would it be
possible to build into these rules a concept that the degree of participation should be flexible and encompass that participation necessary fully to protect the rights and interests of the amici, including, where appropriate to that end, the right fully to
participate in all proceedings as a party? We could develop a standard for involvement by an amicus that avoids the definition likely to be given the term absent an express definition or standard. It would also be helpful to add a statement that the category
of participation is unique to the IRP process, given its specific limitations, and therefore to be defined by the rules themselves and not by reference to other forms of participation in courts or arbitrations such as “amici.”
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Helen <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="371" style="width:278.25pt">
<tbody>
<tr>
<td colspan="2" style="padding:0in 0in 0in 0in">
<p class="MsoNormal"><span style="color:#1F497D"><img border="0" width="464" height="3" style="width:4.8333in;height:.0312in" id="Picture_x0020_1" src="cid:image001.jpg@01D6EE40.E573AF90" alt="Verisign"></span><span style="font-size:12.0pt;color:#1F497D"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:11.25pt 0in 15.0pt 0in">
<p class="MsoNormal" style="line-height:10.5pt"><b><span style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:#006AAA">Helen J. Lee</span></b><span style="font-size:8.5pt;font-family:"Helvetica",sans-serif;color:#6B6D71"><br>
Director and Senior Corporate Counsel<br>
<a href="mailto:hjlee@Verisign.com"><span style="color:blue">hjlee@Verisign.com</span></a><br>
<br>
t: 703-948-4242<br>
12061 Bluemont Way, Reston, VA 20190 <br>
<br>
<a href="http://www.verisigninc.com/"><span style="font-size:9.0pt;color:#006AAA;text-decoration:none">Verisign.com</span></a>
<o:p></o:p></span></p>
</td>
<td valign="top" style="padding:11.25pt 0in 0in 0in">
<p class="MsoNormal"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75" alt="Verisign™" style='position:absolute;margin-left:3.55pt;margin-top:0;width:54.75pt;height:48pt;z-index:251659264;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:right;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:line;mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;mso-height-relative:page' o:allowoverlap="f">
<v:imagedata src="cid:image002.gif@01D6EE40.E573AF90" o:title="Verisign™" />
<w:wrap type="square" anchory="line"/>
</v:shape><![endif]--><![if !vml]><img width="73" height="64" style="width:.7604in;height:.6666in" src="cid:image002.gif@01D6EE40.E573AF90" align="right" alt="Verisign™" v:shapes="Picture_x0020_2"><![endif]><span style="font-size:12.0pt;color:#1F497D"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Times New Roman",serif;color:#1F497D">This e-mail (and any attachments) may contain confidential and/or proprietary information and/or a privileged and confidential attorney-client communication
and/or attorney work product intended solely for the recipient and, therefore, may not be retransmitted or otherwise disseminated to any other person without the prior written consent of the sender. If you have received this e-mail in error, please notify
the sender immediately by telephone or reply e-mail and destroy the original message without making a copy or otherwise using, disseminating, or distributing the contents herein.</span><span style="font-size:10.0pt;font-family:"Times New Roman",serif;color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b>From:</b> IOT <iot-bounces@icann.org> <b>On Behalf Of </b>
Bernard Turcotte<br>
<b>Sent:</b> Monday, January 18, 2021 2:52 PM<br>
<b>To:</b> iot@icann.org<br>
<b>Subject:</b> [EXTERNAL] [IOT] IOT - Regular meeting Tuesday January 19th, 2021 17:00 UTC<o:p></o:p></p>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<table class="MsoNormalTable" border="0" cellpadding="0" width="1185" style="width:888.75pt;background:#F5ECCE">
<tbody>
<tr>
<td width="1175" style="width:881.25pt;padding:.75pt .75pt .75pt .75pt">
<p><strong><span style="font-family:"Calibri",sans-serif;color:#993300">Caution:</span></strong><span style="color:#993300"> </span><span style="color:black">This email originated from outside the organization. Do not click links or open attachments unless
you recognize the sender and know the content is safe. </span><o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<div>
<div>
<p class="MsoNormal"><span style="font-size:12.0pt">Proposed agenda;<o:p></o:p></span></p>
</div>
<div>
<div>
<div>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black"> </span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">1.Review agenda and updates to SOIs<br>
2. Action items from the last meeting:</span><span lang="EN-GB"><o:p></o:p></span></p>
<ul type="disc">
<li class="m921630566209779715msolistparagraph" style="mso-list:l0 level1 lfo1"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">All - review the public comment input from both public comment periods on the topic of the repose</span><span lang="EN-GB" style="font-size:10.0pt"><o:p></o:p></span></li><li class="m921630566209779715msolistparagraph" style="mso-list:l0 level1 lfo1"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">Staff – Prepare a scorecard to track progress vs major items.</span><span lang="EN-GB" style="font-size:10.0pt"><o:p></o:p></span></li></ul>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">3. Brief update on consolidation sub-group meeting.</span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">4. Continue discussions on the time for filing issue:</span><span lang="EN-GB"><o:p></o:p></span></p>
<ul type="disc">
<li class="m921630566209779715msolistparagraph" style="mso-list:l1 level1 lfo2"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">Review and discuss public comment input on the repose (prong 2) – IOT members should attend the meeting
prepared to identify, for discussion, those comments that they consider to be meaningful n this topic
</span><span lang="EN-GB" style="font-size:10.0pt"><o:p></o:p></span></li><li class="m921630566209779715msolistparagraph" style="mso-list:l1 level1 lfo2"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">Time permitting, begin discussion and review public comment input on time for filing from the date Claimant
knew/ought reasonably to have known (prong 1)</span><span lang="EN-GB" style="font-size:10.0pt"><o:p></o:p></span></li></ul>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">5. AOB</span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB" style="font-size:10.0pt;font-family:"Arial",sans-serif">6. Next Meeting - Tuesday 2 February 1900 UTC</span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB"><o:p> </o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB"><o:p> </o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span class="gmaildefault"><span lang="EN-GB" style="font-size:12.0pt">Bernard Turcotte</span></span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span class="gmaildefault"><span lang="EN-GB" style="font-size:12.0pt">ICANN Support to the IOT</span></span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB"><o:p> </o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span class="gmaildefault"><span lang="EN-GB" style="font-size:12.0pt">For</span></span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span class="gmaildefault"><span lang="EN-GB" style="font-size:12.0pt">Susan Payne</span></span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span class="gmaildefault"><span lang="EN-GB" style="font-size:12.0pt">Chair IOT</span></span><span lang="EN-GB"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span lang="EN-GB"><o:p> </o:p></span></p>
</div>
</div>
</div>
</div>
</div>
</body>
</html>